These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 7375013
21. [Clinical and morphological characteristics of long-lasting cholestatic syndrome in patients with hepatitis A in the presence of HBV infection]. Nikiforov ND, Trofimova MN, Ivannikov EV, Mamontov SG, Popov AF. Arkh Patol; 2003; 65(3):29-31. PubMed ID: 12879608 [Abstract] [Full Text] [Related]
22. [Hepatitis B and C: biology and molecular diagnosis]. Blum HE. Verh Dtsch Ges Pathol; 1994; 78():94-103. PubMed ID: 7534024 [Abstract] [Full Text] [Related]
23. [Immunological aspects of acute viral hepatitis treated with corticosteroids]. Singeisen M, Stalder GA, Bianchi L, Gudat F, Schmid M. Schweiz Med Wochenschr; 1977 Dec 03; 107(48):1762-4. PubMed ID: 929138 [Abstract] [Full Text] [Related]
24. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection. Kumar GT, Kazim SN, Kumar M, Hissar S, Chauhan R, Basir SF, Sarin SK. J Gastroenterol Hepatol; 2009 Apr 03; 24(4):588-98. PubMed ID: 19207682 [Abstract] [Full Text] [Related]
25. Effects of immunosuppressive therapy on hepatic expression of hepatitis B viral genome and gene products. Lau JY, Bird GL, Alexander GJ, Williams R. Clin Invest Med; 1993 Jun 03; 16(3):226-36. PubMed ID: 8365050 [Abstract] [Full Text] [Related]
26. The role of HBV DNA and liver histopathology in HBsAg carriers. Agalar C, Diri C, Usubütün S, Agalar F, Türkyïlmaz R. Hepatogastroenterology; 1997 Jun 03; 44(16):1196-9. PubMed ID: 9261624 [Abstract] [Full Text] [Related]
27. Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis. Langrehr JM, Lemmens HP, Keck H, Lohmann R, Knoop M, Neumann U, Müller AR, Platz KP, Kling N, Hopf U. Transplant Proc; 1995 Feb 03; 27(1):1215-6. PubMed ID: 7533373 [No Abstract] [Full Text] [Related]
28. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection. Ranki M, Schätzl HM, Zachoval R, Uusi-Oukari M, Lehtovaara P. Hepatology; 1995 Jun 03; 21(6):1492-9. PubMed ID: 7768492 [Abstract] [Full Text] [Related]
29. [The use of an immunofluorescence technic in the control of chronic HBV hepatitis]. Ciravegna B, Navone C, Calzia R, Giovale M, Zauli C, Piscopo R. Boll Soc Ital Biol Sper; 1982 Aug 30; 58(16):1037-42. PubMed ID: 6753875 [Abstract] [Full Text] [Related]
30. [Should chronic active viral hepatitis be treated with drugs or not?]. Schalm SW. Internist (Berl); 1981 Dec 30; 22(12):717-20. PubMed ID: 7033161 [No Abstract] [Full Text] [Related]
31. Hepatitis gene chip in detecting HBV DNA, HCV RNA in serum and liver tissue samples of hepatitis patients. Zhao W, Wan JM, Liu W, Liu QJ, Zhang L, Zhou ZX, Liu XJ, Zhang HR. Hepatobiliary Pancreat Dis Int; 2003 May 30; 2(2):234-41. PubMed ID: 14599976 [Abstract] [Full Text] [Related]
32. Therapy for hepatitis B virus infection. Perrillo RP, Mason AL. Gastroenterol Clin North Am; 1994 Sep 30; 23(3):581-601. PubMed ID: 7527374 [Abstract] [Full Text] [Related]
33. [Viral hepatitis in drug-addicts: anatomo-clinical correlations]. Camarri E, Corsini P, Marchettini G, Almi P, de' Santi MM, del Vecchio MT, Leoncini L, Cintorino M, Luzi P, Tosi P. Clin Ter; 1984 Aug 31; 110(4):311-26. PubMed ID: 6237867 [No Abstract] [Full Text] [Related]
34. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Fong TL, Di Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH. Hepatology; 1993 Dec 31; 18(6):1313-8. PubMed ID: 8244254 [Abstract] [Full Text] [Related]
35. [Occult hepatitis B virus infection in chronic viral hepatitis patients with non-A to E hepatitis virus infection]. Shang QH, Yu JG, Xu CZ, An Y, Liu FY, Sun SC, Zhang GS. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec 31; 22(6):440-2. PubMed ID: 19544639 [Abstract] [Full Text] [Related]
36. [Active chronic hepatitis. Criteria adopted and results in recent specialist studies]. Carotti A. Minerva Med; 1980 Nov 24; 71(47):3429-34. PubMed ID: 7454095 [No Abstract] [Full Text] [Related]
37. Hepatitis B virus genetic diversity. Echevarría JM, Avellón A. J Med Virol; 2006 Nov 24; 78 Suppl 1():S36-42. PubMed ID: 16622876 [Abstract] [Full Text] [Related]
38. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma. Wu JM, Huang YH, Lee PC, Lin HC, Lee SD. J Clin Gastroenterol; 2009 Nov 24; 43(5):496-8. PubMed ID: 19247200 [Abstract] [Full Text] [Related]
39. Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum. Mariscal LF, Rodríguez-Iñigo E, Bartolomé J, Castillo I, Ortiz-Movilla N, Navacerrada C, Pardo M, Pérez-Mota A, Graus J, Carreño V. J Med Virol; 2004 Jun 24; 73(2):177-86. PubMed ID: 15122790 [Abstract] [Full Text] [Related]
40. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up. Zavaglia C, Bottelli R, Bellati G, Asti L, Mondazzi L, Iamoni G, Zanetti A, Tanzi E, Fesce E, Gelosa F, Maggi G, Ideo G. Ital J Gastroenterol; 1996 Jun 24; 28(6):324-31. PubMed ID: 8891847 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]